Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Decreases Helicobacter - : rifaximin |
📓
Rifaximin: recent advances in gastroenterology and hepatology. Gastroenterology & hepatology (Gastroenterol Hepatol (N Y) ) Vol: 3 Issue 6 Pages: 474-83 Pub: 2007 Jun Epub: Authors Lichtenstein GR , Html Article |
| Decreases Helicobacter - : rifaximin |
👪
Study on the molecular mechanisms of rifaximin in the treatment of non-alcoholic steatohepatitis based on the Helicobacter-DCA-Fxr-Hnf1a signalling pathway. Molecular medicine reports (Mol Med Rep ) Vol: 31 Issue 2 Pages: Pub: 2025 Feb Epub: 2024 Nov 29 Authors Wan YP , Li S , Li D , Huang XM , Wu JH , Jian J , Html Article Publication |
| Decreases Helicobacter - : rifaximin |
👪
Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson`s Disease: Preclinical and Clinical Studies. Cells (Cells ) Vol: 11 Issue 21 Pages: Pub: 2022 Nov 2 Epub: 2022 Nov 2 Authors Hong CT , Chan L , Chen KY , Lee HH , Huang LK , Yang YSH , Liu YR , Hu CJ , Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
